The Influence of Serotonin Deficiency on Choice Deferral and the Compromise Effect
Abstract
Psychological and physiological states such as mood, hunger, stress, and sleep deprivation are known to affect decision-making processes and therefore crucially influence consumer behavior. A possible biological mechanism underlying the observed variability of consumer behavior is the context-sensitive variation in the levels of neuromodulators in the brain. In a series of four experimental studies, the authors pharmaceutically reduce the levels of the neurotransmitter serotonin in the brain to diminish the availability of subjects' cognitive resources. In doing so, they study how serotonin brain levels influence (1) subjects' tendency to avoid buying and (2) consumers' preference for product options positioned as a compromise in a given choice set rather than for more extreme alternatives (i.e., the compromise effect). Using realistic product choice scenarios in a binding decision framework, they find that a reduction of brain serotonin levels leads to choice deferral and decreases the compromise effect, both as a within-subjects and as a between-subjects choice phenomenon. As such, this study provides neurobiological evidence for the assumption that the compromise effect is the result of deliberate and demanding thought processes rather than intuitive decision making.
Additional Information
© 2016 American Marketing Association. The authors thank Paul Bengart, Liri von Petersdorff, and Dr. Stephan Schosser for their valuable support during data collection. Carolyn Yoon served as guest editor for this article.Attached Files
Supplemental Material - jmr_2E14_2E0482-web-appendix.pdf
Files
Name | Size | Download all |
---|---|---|
md5:770de4e857cb3ca14c83c7dd305f98ec
|
185.0 kB | Preview Download |
Additional details
- Eprint ID
- 67427
- Resolver ID
- CaltechAUTHORS:20160527-090718021
- Created
-
2016-05-27Created from EPrint's datestamp field
- Updated
-
2021-11-11Created from EPrint's last_modified field